Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
Tegaserod (HTF919) is an aminoguanidine indole compound and a member of a new class of
subgroup-selective 5-hydroxytryptamine (5-HT) agonists. The aim of this study is to
investigate the efficacy, safety and tolerability of tegaserod on bowel habits in patients
with CC.